DK1750700T3 - Veterinærmedicinsk væskepræparat, fremgangsmåde til fremstilling af dette samt anvendelse deraf - Google Patents

Veterinærmedicinsk væskepræparat, fremgangsmåde til fremstilling af dette samt anvendelse deraf

Info

Publication number
DK1750700T3
DK1750700T3 DK05748118T DK05748118T DK1750700T3 DK 1750700 T3 DK1750700 T3 DK 1750700T3 DK 05748118 T DK05748118 T DK 05748118T DK 05748118 T DK05748118 T DK 05748118T DK 1750700 T3 DK1750700 T3 DK 1750700T3
Authority
DK
Denmark
Prior art keywords
preparation
veterinary liquid
veterinary
liquid preparation
liquid
Prior art date
Application number
DK05748118T
Other languages
Danish (da)
English (en)
Inventor
Martin Folger
Bernhard Hassel
Stefan Henke
Dietrich W Janott
Peter Riechel
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Application granted granted Critical
Publication of DK1750700T3 publication Critical patent/DK1750700T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK05748118T 2004-05-19 2005-05-04 Veterinærmedicinsk væskepræparat, fremgangsmåde til fremstilling af dette samt anvendelse deraf DK1750700T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004025324A DE102004025324A1 (de) 2004-05-19 2004-05-19 Flüssige Zubereitung für die Veterinärmedizin, Verfahren zu deren Herstellung und deren Verwendung
PCT/EP2005/004824 WO2005115386A1 (fr) 2004-05-19 2005-05-04 Preparation liquide destinee a la medecine veterinaire, procede de fabrication et utilisation de ladite preparation

Publications (1)

Publication Number Publication Date
DK1750700T3 true DK1750700T3 (da) 2008-02-04

Family

ID=34969447

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05748118T DK1750700T3 (da) 2004-05-19 2005-05-04 Veterinærmedicinsk væskepræparat, fremgangsmåde til fremstilling af dette samt anvendelse deraf

Country Status (13)

Country Link
US (1) US20050277634A1 (fr)
EP (1) EP1750700B1 (fr)
AR (1) AR048965A1 (fr)
AT (1) ATE382350T1 (fr)
CY (1) CY1107353T1 (fr)
DE (2) DE102004025324A1 (fr)
DK (1) DK1750700T3 (fr)
ES (1) ES2300027T3 (fr)
PL (1) PL1750700T3 (fr)
PT (1) PT1750700E (fr)
SI (1) SI1750700T1 (fr)
TW (1) TW200611694A (fr)
WO (1) WO2005115386A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1568369A1 (fr) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Utilisation du meloxicam pour le traitement de maladies respiratoires des porcs
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
EP1942902A1 (fr) * 2005-09-30 2008-07-16 Boehringer Ingelheim Vetmedica Gmbh Preparation pharmaceutique qui contient du meloxicam
ES2633020T3 (es) 2006-12-10 2017-09-18 Yu, Chongxi-Techfields Biochem Sistemas de administración transdérmica de antibióticos betalactámicos
US9969751B2 (en) * 2009-06-10 2018-05-15 Techfields Pharma Co., Ltd. High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds
JP5559339B2 (ja) 2009-10-12 2014-07-23 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング メロキシカムを含む組成物のための容器
BR112012022073A2 (pt) 2010-03-03 2017-10-31 Boehringer Ingelheim Vetmedica Gmbh uso de meloxicam para o tratamento de longa duração de distúrbios musculoesqueletais em gatos.
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
NZ588686A (en) * 2011-01-20 2013-07-26 Bayer New Zealand Ltd Injectable composition comprising an NSAID and an antibiotic in a non-aqueous solvent for treating a microbial infection in a mammary gland
KR102309973B1 (ko) 2012-01-18 2021-10-06 테크필즈 파마 코., 엘티디. 폐 병태의 치료를 위한 고침투 전구약물 조성물 및 그의 약제학적 조성물
MY172561A (en) * 2012-07-17 2019-12-03 Bayer New Zealand Ltd Injectable antibiotic formulations and their methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE49770B1 (en) * 1979-05-21 1985-12-11 Leo Pharm Prod Ltd 6beta-halopenicillanic acid derivatives
IE51846B1 (en) * 1980-11-17 1987-04-15 Leo Pharm Prod Ltd Pharmaceutical preparation for veterinary use and an appliance containing it
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
DE10161077A1 (de) * 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion

Also Published As

Publication number Publication date
SI1750700T1 (sl) 2008-06-30
DE502005002419D1 (de) 2008-02-14
DE102004025324A1 (de) 2005-12-08
WO2005115386A1 (fr) 2005-12-08
AR048965A1 (es) 2006-06-14
EP1750700A1 (fr) 2007-02-14
TW200611694A (en) 2006-04-16
PT1750700E (pt) 2008-01-18
PL1750700T3 (pl) 2008-06-30
CY1107353T1 (el) 2012-12-19
ATE382350T1 (de) 2008-01-15
ES2300027T3 (es) 2008-06-01
US20050277634A1 (en) 2005-12-15
EP1750700B1 (fr) 2008-01-02

Similar Documents

Publication Publication Date Title
DK1750700T3 (da) Veterinærmedicinsk væskepræparat, fremgangsmåde til fremstilling af dette samt anvendelse deraf
DE602005017393D1 (de) Flüssigkeitszerstäubungssystem und -verfahren
DK1805312T3 (da) Fremgangsmåder og midler til fremstilling af hyaluronan
DK1755743T3 (da) Beta-hydroxybutyrat og derivater til behandling af depression og angst
CR10709A (es) Determinadas amidas sustituidas, metodo de elaboracion y metodo de uso de las mismas
DK1905443T3 (da) Væske omfattende trehalose til anvendelse ved forhindring af vævsadhæsion
NO20055686L (no) Sammensetning, fremgangsmate til fremstilling derav, og anvendelse derav.
DK2902053T3 (da) Anordninger, systemer og fremgangsmåder til væskefremføring
CL2005002823A1 (es) Anticuerpos anti-virus respiratorio sincitial, antigenos y usos de los mismos
BRPI0615559A2 (pt) sistema e método de autenticação de usúario de rede
FI20041323A (fi) Analysoija, järjestelmä ja menetelmä toivotun käyttäjäjoukon määrittämiseksi
DK1747290T3 (da) Anvendelse af fuldblod i PCR reaktioner
DK1656370T3 (da) Heterocykliske biarylforbindelser og fremgangsmåder til fremstilling og anvendelse af samme
FI20050357A0 (fi) Matkapäätelaitteen tarkan sijainnin määrittäminen, menetelmä ja laite
DK1802386T3 (da) Maskinanlæg til farvning samt fremgangsmåde
DK1768833T3 (da) Formlegeme, fremgangsmåde til dets fremstilling samt dets anvendelse
DE602005001520D1 (de) Zeiteinstellungssystem und Zeiteinstellungsverfahren
DE602005014898D1 (de) Flüssigkeitssensor und Verfahren
BRPI0913739A2 (pt) Composição líquida, método, e, uso de composição
DK1802749T3 (da) KASPP (LRRK2)-gen, dets fremstilling og anvendelse til påvisning og behandling af neurodegenerative lidelser
DK1601359T3 (da) Væskeformige, farmaceutiske formuleringer af palonosetron
EP1797186A4 (fr) Systeme d'expression, composants de ce systeme d'expression, et procedes d'utilisation
DE602005025710D1 (de) Flüssigkeits-Abstreifvorrichtung
EP2029783A4 (fr) Fixateur biologique et procédé d'utilisation du fixateur biologique
ATE382261T1 (de) Flüssige formulierung